Low-dose colchicine therapy may not alter pericoronary adipose tissue attenuation but can help in improving plaque stability ...

A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

Stevan Patterson at an 80th anniversary VE and VJ day event in Castlderg on Saturday, 24th May unveiled a plaque to mark 85 years since Harry Ferguson presented Henry Ford with a plaque/money clip in ...

Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case?

Local broadcasting celebrity Graham Liver from BBC Radio Lancashire, will unveil two commemorative plaques donated to The ...

Celltrion announces US FDA approval of additional presentation of Steqeyma, expanding dosing options for paediatric patients: Incheon, South Korea Tuesday, June 17, 2025, 16:00 Hr ...

A fallen firefighter from the Inland Northwest will be honored alongside other fallen firefighters from around Washington in ...

The Washington State Fire Service is inviting the community to attend the Washington State Fallen Firefighter’s Memorial ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...